Cargando…
Clinical Features of Olfactory Dysfunction in COVID-19 Patients
BACKGROUND: The aim of this study was to evaluate the subjective and objective olfactory function in coronavirus disease 2019 (COVID-19) patients and the effect of olfactory training. METHODS: A prospective cohort study was performed in 53 patients who recovered from COVID-19 and visited our tertiar...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Medical Sciences
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8185125/ https://www.ncbi.nlm.nih.gov/pubmed/34100564 http://dx.doi.org/10.3346/jkms.2021.36.e161 |
_version_ | 1783704720713449472 |
---|---|
author | Seo, Min Young Choi, Won Suk Lee, Seung Hoon |
author_facet | Seo, Min Young Choi, Won Suk Lee, Seung Hoon |
author_sort | Seo, Min Young |
collection | PubMed |
description | BACKGROUND: The aim of this study was to evaluate the subjective and objective olfactory function in coronavirus disease 2019 (COVID-19) patients and the effect of olfactory training. METHODS: A prospective cohort study was performed in 53 patients who recovered from COVID-19 and visited our tertiary hospital. Subjective olfactory function was evaluated using the 11-point Likert scale (0–10) and the Korean version of the Questionnaire of Olfactory Disorders (QOD). Objective olfactory function was evaluated using Cross-Cultural Smell Identification Test (CC-SIT). Confirmed patients were followed up after 2 months of olfactory training. RESULTS: The median, interquartile range (Q1–Q3) score of subjective olfactory function significantly deteriorated in patients with olfactory dysfunction (OD) than in those without OD, even after 3 months of onset (11-point Likert scale, 8, 6–9 vs. 10, 10–10; short version of QOD-negative statements, 19, 16–21 vs. 21, 21–21; QOD-visual analogue scale, 7, 1–13 vs. 0, 0–0; all P < 0.001). However, the objective olfactory function was not significantly different between the two groups (median, interquartile range; 11, 9–11 vs. 11, 9–11, P = 0.887). The percentage of patients with objective hyposmia (CC-SIT ≤ 10) was also not significantly different (47.4% vs. 40%, P = 0.762). OD in COVID-19 was normalized after 2 months of olfactory training in 70% of patients even after 3 months of olfactory impairment. CONCLUSION: Although subjective olfactory function is significantly decreased in the OD group, the objective olfactory function was not significantly different. Moreover, olfactory training is effective in COVID-19 patients with OD. |
format | Online Article Text |
id | pubmed-8185125 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | The Korean Academy of Medical Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-81851252021-06-15 Clinical Features of Olfactory Dysfunction in COVID-19 Patients Seo, Min Young Choi, Won Suk Lee, Seung Hoon J Korean Med Sci Original Article BACKGROUND: The aim of this study was to evaluate the subjective and objective olfactory function in coronavirus disease 2019 (COVID-19) patients and the effect of olfactory training. METHODS: A prospective cohort study was performed in 53 patients who recovered from COVID-19 and visited our tertiary hospital. Subjective olfactory function was evaluated using the 11-point Likert scale (0–10) and the Korean version of the Questionnaire of Olfactory Disorders (QOD). Objective olfactory function was evaluated using Cross-Cultural Smell Identification Test (CC-SIT). Confirmed patients were followed up after 2 months of olfactory training. RESULTS: The median, interquartile range (Q1–Q3) score of subjective olfactory function significantly deteriorated in patients with olfactory dysfunction (OD) than in those without OD, even after 3 months of onset (11-point Likert scale, 8, 6–9 vs. 10, 10–10; short version of QOD-negative statements, 19, 16–21 vs. 21, 21–21; QOD-visual analogue scale, 7, 1–13 vs. 0, 0–0; all P < 0.001). However, the objective olfactory function was not significantly different between the two groups (median, interquartile range; 11, 9–11 vs. 11, 9–11, P = 0.887). The percentage of patients with objective hyposmia (CC-SIT ≤ 10) was also not significantly different (47.4% vs. 40%, P = 0.762). OD in COVID-19 was normalized after 2 months of olfactory training in 70% of patients even after 3 months of olfactory impairment. CONCLUSION: Although subjective olfactory function is significantly decreased in the OD group, the objective olfactory function was not significantly different. Moreover, olfactory training is effective in COVID-19 patients with OD. The Korean Academy of Medical Sciences 2021-05-26 /pmc/articles/PMC8185125/ /pubmed/34100564 http://dx.doi.org/10.3346/jkms.2021.36.e161 Text en © 2021 The Korean Academy of Medical Sciences. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Seo, Min Young Choi, Won Suk Lee, Seung Hoon Clinical Features of Olfactory Dysfunction in COVID-19 Patients |
title | Clinical Features of Olfactory Dysfunction in COVID-19 Patients |
title_full | Clinical Features of Olfactory Dysfunction in COVID-19 Patients |
title_fullStr | Clinical Features of Olfactory Dysfunction in COVID-19 Patients |
title_full_unstemmed | Clinical Features of Olfactory Dysfunction in COVID-19 Patients |
title_short | Clinical Features of Olfactory Dysfunction in COVID-19 Patients |
title_sort | clinical features of olfactory dysfunction in covid-19 patients |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8185125/ https://www.ncbi.nlm.nih.gov/pubmed/34100564 http://dx.doi.org/10.3346/jkms.2021.36.e161 |
work_keys_str_mv | AT seominyoung clinicalfeaturesofolfactorydysfunctionincovid19patients AT choiwonsuk clinicalfeaturesofolfactorydysfunctionincovid19patients AT leeseunghoon clinicalfeaturesofolfactorydysfunctionincovid19patients |